Evidence tier

Emerging Compounded Medications

Compounded medications with promising but limited human trial data. Use is investigational in nature and should be paired with informed clinician judgment and patient-specific monitoring.

RonanRx is a 503A compounding pharmacy. Compounded medications are patient-specific and require a valid prescription. They are not FDA-approved drug products. Evidence tiers describe the published research base for the active ingredient; they do not constitute medical advice.